AVR
Anteris Technologies Global Corp. Common Stock
NASDAQ: AVR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$6.15
+4.24% today
Updated 2026-04-30
Market cap
$542.55M
P/E ratio
—
P/S ratio
283.61x
EPS (TTM)
$-2.55
Dividend yield
—
52W range
$3 – $7
Volume
0.9M
Anteris Technologies Global Corp. Common Stock (AVR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $5.46M | $5.83M | $3.20M | $2.73M | $2.70M | $1.91M |
| Revenue growth (YoY) | — | +6.8% | -45.1% | -14.6% | -1.2% | -29.2% |
| Cost of revenue | $2.10M | $3.93M | $2.90M | $1.86M | $1.44M | $569000.00 |
| Gross profit | $3.36M | $1.91M | $298383.00 | $876800.00 | $1.27M | $1.34M |
| Gross margin | 61.5% | 32.7% | 9.3% | 32.1% | 46.8% | 70.3% |
| R&D | $3.57M | $9.99M | $17.59M | $31.02M | $51.45M | $69.12M |
| SG&A | $2.18M | $8.72M | $14.41M | $15.96M | — | — |
| Operating income | $-13.26M | $-16.86M | $-31.11M | $-48.14M | $-78.37M | $467000.00 |
| Operating margin | -243.0% | -289.2% | -972.1% | -1760.3% | -2899.4% | 24.4% |
| EBITDA | $-14.05M | $-15.50M | $-29.14M | $-45.54M | $-76.86M | $-92.49M |
| EBITDA margin | -257.5% | -265.8% | -910.5% | -1665.1% | -2843.7% | -4834.9% |
| EBIT | $-14.63M | $-16.14M | $-29.92M | $-46.70M | $-78.37M | $-94.15M |
| Interest expense | $300641.00 | $1.03M | $648709.00 | $67089.00 | $82000.00 | $73000.00 |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-11.78M | $-17.17M | $-30.56M | $-46.02M | $-76.29M | $-94.22M |
| Net income growth (YoY) | — | -45.8% | -78.0% | -50.6% | -65.8% | -23.5% |
| Profit margin | -215.8% | -294.5% | -954.9% | -1682.8% | -2822.5% | -4925.5% |